Panel Discussion

Sunday, March 9, 2025

7:40 PM – 7:50 PM ET

Panel Moderator(s)

C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing)
Neal S. Kleiman, MD, FACC, MSCAI

Medical Director, Cardiac Catheterization Laboratories
Houston Methodist DeBakey Heart and Vascular Center
Houston, Texas, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); Medtronic: Consultant (Ongoing)

Panel Discussant(s)

Usman Baber, MD, MS

Professor of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States

Disclosure(s): Abbott Cardiovascular Systems: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Colin Barker, Sr., MD

Director
VUMC
Nashville, Tennessee, United States

Disclosure(s): No financial relationships to disclose
Ankur Kalra, MD

Interventional Cardiologist
Franciscan Health, United States

Disclosure(s): No financial relationships to disclose
AK

Ajar Kochar, MD, MHS

Program Director
Brigham and Women's Hospital/Harvard Medical School
CHESTNUT HILL, Massachusetts, United States

Disclosure(s): Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); American Heart Association: Grant/Research Support (Ongoing); Faraday Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Rampart Medical: Grant/Research Support (Ongoing); Shockwave Inc: Grant/Research Support (Ongoing)
Srihari S. Naidu, MD, FSCAI

Director, Cath Labs and HCM Program
Westchester Medical Center
Valhalla, New York, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

C. Michael Gibson, MD: Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing)

Neal S. Kleiman, MD, FACC, MSCAI: Abbott Labs: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); Medtronic: Consultant (Ongoing)

Usman Baber, MD, MS: Abbott Cardiovascular Systems: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Colin Barker, MD, Sr.: No financial relationships to disclose

Ankur Kalra, MD: No financial relationships to disclose

Ajar Kochar, MD, MHS: Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); American Heart Association: Grant/Research Support (Ongoing); Faraday Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Rampart Medical: Grant/Research Support (Ongoing); Shockwave Inc: Grant/Research Support (Ongoing)

Srihari S. Naidu, MD, FSCAI: No financial relationships to disclose